What Researchers Did
Researchers studied how hyperbaric oxygen therapy, given as 30 treatments over 6 weeks, affected patients with ulcerative and non-ulcerative interstitial cystitis.
What They Found
Of the six patients with ulcerative interstitial cystitis (UIC), 83% reported improvement on a global response assessment, with 66% remaining better at 6 months. Pain scores for UIC patients improved by 2 points, and ulcers resolved in two patients by 6-month cystoscopy. In contrast, only one of the two non-ulcerative interstitial cystitis (NIC) patients improved, and their pain scores worsened by 1.5 points, though questionnaire scores improved in both groups.
What This Means for Canadian Patients
For Canadian patients suffering from interstitial cystitis, particularly those with the ulcerative form, this pilot study suggests that hyperbaric oxygen therapy might offer a new treatment option for symptom relief. While the findings are preliminary, they indicate potential for reducing pain and improving overall well-being for some patients, especially those with Hunner's ulcers.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a pilot study with a very small number of participants, limiting the generalizability and statistical power of the findings.